In non-Hodgkin’s lymphoma, acute and chronic myeloblastic leukemia and chronic lymphocytic leukemia high levels of TNF-α and its receptors are associated with poor outcome and therapy resistance [6, 7]. Here, TNF is linked to B-cell chronic lymphocytic leukemia.